This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
T.K. Birkenhager , W.W. van den Broek , P.G. Mulder , J.A. Bruijn and P. Moleman (2004) Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. American Journal of Psychiatry 161, 2060–2065.
L. Bjerkenstedt , L. Flyckt , K.F. Overo and O. Lingjaerde (1985) Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels. European Journal of Clinical Pharmacology 28, 553–557.
C. Bolden-Watson and E. Richelson (1993) Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Science 52, 1023–1029.
N.R. Bolo , Y. Hode , J.F. Nedelec , E. Laine , G. Wagner and J.P. Macher (2000) Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 23, 428–438.
D.W. Bonhaus , C. Bach , A. DeSouza , F.H. Salazar , B.D. Matsuoka , P. Zuppan (1995) The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. British Journal of Pharmacology 115, 622–628.
M.M. Bradford (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72, 248–254.
Y. Chen , L. Peng , X. Zhang , J.U. Stolzenburg and L. Hertz (1995) Further evidence that fluoxetine interacts with a 5-HT2C receptor in glial cells. Brain Research Bulletin 38, 153–159.
D.C. Deecher , B.D. Wilcox , V. Dave , P.A. Rossman and H.K. Kimelberg (1993) Detection of 5-hydroxytryptamine2 receptors by radioligand binding, northern blot analysis, and Ca2+ responses in rat primary astrocyte cultures. Journal of Neuroscience Research 35, 246–256.
C.L. DeVane , H.L. Liston and J.S. Markowitz (2002) Clinical pharmacokinetics of sertraline. Clinical Pharmacokinetics 41, 1247–1266.
M. El Marjou , V. Montalescot , A. Buzyn and B. Geny (2000) Modifications in phospholipase D activity and isoform expression occur upon maturation and differentiation in vivo and in vitro in human myeloid cells. Leukemia 14, 2118–2127.
G. Feng , R.H. Mellor , M. Bernstein , C. Keller-Peck , Q.T. Nguyen , M. Wallace (2000) Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28, 41–51.
M.P. Freeman , P.E. Nolan Jr., M.F. Davis , M. Anthony , K. Fried , M. Fankhauser (2008) Pharmacokinetics of sertraline across pregnancy and postpartum. Journal of Clinical Psychopharmacology 28, 646–653.
E. Hansson , P. Simonsson and C. Alling (1987) 5-Hydroxytryptamine stimulates the formation of inositol phosphate in astrocytes from different regions of the brain. Neuropharmacology 26, 1377–1382.
M.E. Henry , M.E. Schmidt , J. Hennen , R.A. Villafuerte , M.L. Butman , P. Tran (2005) A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: a 19-F MRS study. Neuropsychopharmacology 30, 1576–1583.
L. Hertz , A. Schousboe , N. Boechler , S. Mukerji and S. Fedoroff (1978) Kinetic characteristics of the glutamate uptake into normal astrocytes in cultures. Neurochemical Research 3, 1–14.
L. Hertz (2008) Bioenergetics of cerebral ischemia: a cellular perspective. Neuropharmacology 55, 289–309.
L. Hertz , A.S. Bender , D.M. Woodbury and H.S. White (1989) Potassium-stimulated calcium uptake in astrocytes and its potent inhibition by nimodipine. Journal of Neuroscience Research 22, 209–215.
L. Hertz , D. Lovatt , S.A. Goldman and M. Nedergaard (2010) Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2 + )](i). Neurochemistry International. April 7, Epub ahead of print.
L. Hertz , L. Peng and J.C. Lai (1998) Functional studies in cultured astrocytes. Methods 16, 293–310.
K. Hirano , R. Kimura , Y. Sugimoto , J. Yamada , S. Uchida , Y. Kato (2005) Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. British Journal of Pharmacology 144, 695–702.
J. Hyttel (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology 9 supp. 1, 19–26.
J. Hyttel , K.F. Overo and J. Arnt (1984) Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram. Psychopharmacology (Berlin) 83, 20–27.
A.I. Ivanov , R.S. Pero , A.C. Scheck and A.A. Romanovsky (2002) Prostaglandin E(2)-synthesizing enzymes in fever: differential transcriptional regulation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 283, R1104–R1117.
W.J. Jusko and M. Gretch (1976) Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metabolism Reviews 5, 43–140.
J.M. Kent , J.D. Coplan , I. Lombardo , D.R. Hwang , Y. Huang , O. Mawlawi (2002) Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652. Psychopharmacology (Berlin) 164, 341–348.
E.K. Kong , L. Peng , Y. Chen , A.C. Yu and L. Hertz (2002) Up-regulation of 5-HT2B receptor density and receptor-mediated glycogenolysis in mouse astrocytes by long-term fluoxetine administration. Neurochemical Research 27, 113–120.
Q. Li , L. Ma , R.B. Innis , N. Seneca , M. Ichise , H. Huang (2004) Pharmacological and genetic characterization of two selective serotonin transporter ligands: 2-[2-(dimethylaminomethylphenylthio)]-5-fluoromethylphenylamine (AFM) and 3-amino-4-[2-(dimethylaminomethyl-phenylthio)]benzonitrile (DASB). Journal of Pharmacology and Experimental Therapeutics 308, 481–486.
B. Li , S. Zhang , M. Li , L. Hertz and L. Peng (2009) Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation. Psychopharmacology (Berlin) 207, 1–12.
B. Li , S. Zhang , H. Zhang , W. Nu , L. Cai , L. Hertz (2008) Fluoxetine-mediated 5-HT(2B) receptor stimulation in astrocytes causes EGF receptor transactivation and ERK phosphorylation. Psychopharmacology (Berlin) 201, 443–458.
X. Liu , K. Van Natta , H. Yeo , O. Vilenski , P.E. Weller , P.D. Worboys (2009) Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid. Drug Metabolism and Disposition: The Biological Fate of Chemicals 37, 787–793.
D. Lovatt , U. Sonnewald , H.S. Waagepetersen , A. Schousboe , W. He , J.H. Lin (2007) The transcriptome and metabolic gene signature of protoplasmic astrocytes in the adult murine cortex. The Journal of Neuroscience 27, 12255–12266.
H. Manev , T. Uz and R. Manev (2003) Glia as a putative target for antidepressant treatments. Journal of Affective Disorders 75, 59–64.
E. Meier , L. Hertz and A. Schousboe (1991) Neurotransmitters as developmental signals. Neurochemistry International 19, 1–15.
J.H. Meyer , S. McMain , S.H. Kenedy , L. Korman , G.M. Brown , J.N. DaSilva , A.A. Wilson , T. Blak , R. Eynan-Harvey , V.S. Goulding , S. Houle and P. Links (2003) Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. American Journal of Psychiatry 160, 90–99.
J.H. Meyer , S. Kapur , B. Eisfeld , G.M. Brown , S. Houle , J. DaSilva (2001) The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. American Journal of Psychiatry 158, 78–85.
J.H. Meyer , A.A. Wilson , S. Sagrati , D. Hussey , A. Carella , W.Z. Potter (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. American Journal of Psychiatry 161, 826–835.
M. Nilsson , E. Hansson and L. Ronnback (1991) Adrenergic and 5-HT2 receptors on the same astroglial cell. A microspectrofluorimetric study on cytosolic Ca2+ responses in single cells in primary culture. Brain Research. Developmental Brain Research 63, 33–41.
L. Peng , B. Li , T. Du , E.K. Kong , X. Hu , S. Zhang (2010) Astrocytic transactivation by alpha(2)-adrenergic and 5-HT(2B) serotonergic signaling. Neurochemistry International, May 7, Epub ahead of print.
J.C. Poblete and E.C. Azmitia (1995) Activation of glycogen phosphorylase by serotonin and 3,4-methylenedioxymethamphetamine in astroglial-rich primary cultures: involvement of the 5-HT2A receptor. Brain Research 680, 9–15.
J.S. Rao , R.N. Ertley , H.J. Lee , S.I. Rapoport and R.P. Bazinet (2006) Chronic fluoxetine upregulates activity, protein and mRNA levels of cytosolic phospholipase A2 in rat frontal cortex. Pharmacogenomics Journal 6, 413–420.
M. Reis and B. Kallen (2010) Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychological Medicine. Jan. 5, Epub ahead of print.
C.J. Rhodes , A. Davidson , J.S. Gibbs , J. Wharton and M.R. Wilkins (2009) Therapeutic targets in pulmonary arterial hypertension. Pharmacology and Therapeutics 121, 69–88.
R.B. Rothman and M.H. Baumann (2009) Serotonergic drugs and valvular heart disease. Expert Opinion on Drug Safety 8, 317–329.
R.B. Rothman , M.H. Baumann , J.E. Savage , L. Rauser , A. McBride , S.J. Hufeisen (2000) Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications. Circulation 102, 2836–2841.
N. Sanden , T. Thorlin , F. Blomstrand , P.A. Persson and E. Hansson (2000) 5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions. Neurochemistry International 36, 427–434.
K. Sawamura , Y. Suzuki and T. Someya (2004) Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine. European Journal of Clinical Pharmacology 60, 553–557.
M. Seki , H. Nawa , T. Morioka , T. Fukuchi , T. Oite , H. Abe (2002) Establishment of a novel enzyme-linked immunosorbent assay for Thy-1; quantitative assessment of neuronal degeneration. Neuroscience Letters 329, 185–188.
D.K. Sit , J.M. Perel , J.C. Helsel and K.L. Wisner (2008) Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. Journal of Clinical Psychiatry 69, 652–658.
M.E. Sublette , M.S. Milak , J.R. Hibbeln , P.J. Freed , M.A. Oquendo , K.M. Malone (2009) Plasma polyunsaturated fatty acids and regional cerebral glucose metabolism in major depression. Prostaglandins, Leukotrienes and Essential Fatty Acids 80, 57–64.
M. Tatsumi , K. Groshan , R.D. Blakely and E. Richelson (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. European Journal of Pharmacology 340, 249–258.
J. van Harten (1993) Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clinical Pharmacokinetics 24, 203–220.
A.N. Voineskos , A.A. Wilson , A. Boovariwala , S. Sagrati , S. Houle , P. Rusjan (2007) Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography. Psychopharmacology (Berlin) 193, 539–545.
A.M. Weissman , B.T. Levy , A.J. Hartz , S. Bentler , M. Donohue , V.L. Ellingrod (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. American Journal of Psychiatry 161, 1066–1078.
S.M. Wille , S.G. Cooreman , H.M. Neels and W.E. Lambert (2008) Relevant issues in the monitoring and the toxicology of antidepressants. Critical Reviews in Clinical Laboratory Sciences 45, 25–89.
A.A. Wilson , N. Ginovart , D. Hussey , J. Meyer and S. Houle (2002) In vitro and in vivo characterisation of [11C]-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography. Nuclear Medicine and Biology 29, 509–515.
D.T. Wong and F.P. Bymaster (1995) Development of antidepressant drugs. Fluoxetine (Prozac) and other selective serotonin uptake inhibitors. Advances in Experimental Medicine and Biology 363, 77–95.
N. Yu , J.L. Martin , N. Stella and P.J. Magistretti (1993) Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proceedings of the National Academy of Sciences of the U.S.A. 90, 4042–4046.